May 14 (Reuters) - EyePoint said on Thursday an independent safety committee found no new concerns in two late-stage trials of its experimental eye disease drug Duravyu and recommended the studies ...

GLP-1 drugs like Ozempic could lead to a higher risk of wet age-related macular degeneration in people with type 2 diabetes. Westend61/Getty Images GLP-1 drugs are linked to a significantly higher ...

Significantly lower AMD risk compared with other agents in cohort study ...

Many of us are painfully aware of our body's increasing number of shortcomings as we get older. Sagging skin, hearing loss, receding hairlines and tending to use the bathroom more frequently than we ...

Resolution occurred after stopping dulaglutide, no obvious clues to mechanism ...

The European Medicines Agency (EMA) has announced its approval of two new biosimilar medications, Afqlir and Opuviz, to treat age-related macular degeneration (ARMD). The active ingredient of both ...

Age-related macular degeneration, the leading cause of vision loss and blindness for Americans 65 and older, is a progressive disease affecting central vision. Over time, faces, book pages and ...

A clinical trial is typically the first look at how an experimental drug works in humans. Character Biosciences is entering the clinic with a trove of company-generated human data already in hand.

Patients with mild heart failure stand to benefit from a new drug that can halt the progression of their disease and reduce their risk of cardiovascular-related death. But the drug -- a tablet that ...

BOSTON — A new antivascular endothelial growth-factor (VEGF) drug, OPT-302 (Opthea), appears to be safe and shows signs of effectiveness in the treatment of neovascular age-related macular ...

Add Yahoo as a preferred source to see more of our stories on Google. Many of us are painfully aware of our body's increasing number of shortcomings as we get older. Sagging skin, hearing loss, ...